NP-1116

N/A

Report date: 2024/01/03 15:38:50

Base Information

Drug NameNP-1116
Drug Alias NameNP-1116NP1116
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionGonadotropin-releasing hormone agonists
TargetsGonadotropin-releasing hormone
Therapy Area/IndicationsPuberty, PrecociousProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesNovel Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesNovel Pharma Inc
Inactive CompaniesN/A
Active IndicationsPuberty, PrecociousProstatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A